- Tytuł:
- A pivotal bridging study of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer.
- Autorzy:
- Źródło:
- Scientific reports [Sci Rep] 2024 Feb 13; Vol. 14 (1), pp. 3598. Date of Electronic Publication: 2024 Feb 13.
- Typ publikacji:
- Clinical Trial, Phase I; Journal Article; Multicenter Study
- MeSH Terms:
-
Anemia*/etiology
Carbolines*/adverse effects
HeterocyclicCompounds ,4 or More Rings*/adverse effects
Lung Neoplasms*/pathology
Neutropenia*/drug therapy
Small Cell Lung Carcinoma*/pathology
Thrombocytopenia*/etiology
Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; China
Czasopismo naukowe